For DSS, high expression of HSP90AA1 in BLCA, LIHC, LUAD, MESO and PAAD had unfavorable prognosis but KIRC patients with higher expression of HSP90AA1 indicated better prognosis (Figure 5C). Here, HSP90AA1 is linked to bladder transitional cell carcinoma.